Sanuwave Health, Inc. SNWV 深 滬
等待開盤 11-17 09:30:00 美东时间
32.97
-0.590
-1.76%
華盛通- 最 高34.31
- 今 開34.14
- 成交量 9.64万股
- 最 低 32.47
- 昨 收 33.56
- 總市值 2.82亿
- 52周最高 46.585
- 市盈率 靜 --
- 換手率 1.12%
- 52周最低 24.80
- 委 比 2.91%
- 總股本 856.80万
- 歷史最高 46.585
- 量 比 0.55
- 振 幅 5.48%
- 歷史最低 24.80
- 每 手 1
- 風險率 4.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SANUWAVE Health Q3 EPS $0.46 Beats $0.32 Estimate, Sales $11.451M Beat $11.430M Estimate
SANUWAVE Health (OTC:SNWV) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.32 by 43.75 percent. This is a 107.09 percent increase over losses of $(6.49) per share from the
11-07 05:58
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
An Overview of SANUWAVE Health's Earnings
SANUWAVE Health (OTC:SNWV) will release its quarterly earnings report on Thursd...
11-06 04:03
Sanuwave Health Said Centers For Medicare & Medicaid Services' 2026 Rates For Physician Offices, Home Visits, Long-term Care, And Hospitals Are In Line With The Proposed Rule And Remain Materially Unchanged From 2025
Reimbursement for the 97610 code for UltraMIST products remains materially unchanged for 2026 with payment for treatment provided in the physician office, home visit, long-term care, and hospital settings remaining
11-03 18:05
Sanuwave Health Terminates President Andrew Walko
Sanuwave Health ( ($SNWV) ) just unveiled an update. On September 25, 2025, San...
10-31 05:28
SANUWAVE Health shares are trading lower after the company issued preliminary Q3 revenue results below estimates. Also, the company cut its FY25 revenue guidance.
SANUWAVE Health shares are trading lower after the company issued preliminary Q...
10-07 04:25
Sanuwave Health expects Q3 revenue between $11.4M and $11.6M
Sanuwave Health (NASDAQ:SNWV) announced on Monday that its revenues for the third quarter of 2025 are expected to be in the range of $11.4 to $11.6 million versus consensus of $12.37 million, an incre...
10-07 04:10
Sanuwave refinances debt with new credit facility
Sanuwave Health (NASDAQ:SNWV) has announced the refinancing of its $27.5M debt facility with a $23.0M new secured credit facility from J.P. Morgan, 1.0M withdrawn from a two-year $5.0M revolving credi...
09-26 22:46
Sanuwave Announces Strategic Debt Refinancing with New Credit Facility
<p><p align="center"><em>Credit facility from J.P. Morgan consists of a four-year term loan of $23 million and a two-year $5 million revolving credit facility backed by accounts receivable</em></p> <p align="center"><em>Both the term loan and revolver have an interest rate of SOFR +350bp</em></p> <p align="center"><em>The Company drew approximately $1 million from the revolver at commencement, resulting in total outstanding debt under the new fac...
09-26 11:00
美股大行评级 | 潜在涨幅403.28%！瑞杰金融首予Kalaris Therapeutics"强烈买入"评级，目标价23美元
今日重点评级关注：花旗：维持Ionis Pharmaceuticals"买入"评级，目标价从69美元升至84美元；Melius Research：上调康明斯评级至"买入"，目标价500美元
09-04 09:49
